01:43 PM EDT, 10/16/2024 (MT Newswires) -- Renovaro ( RENB ) said Wednesday it has named David Weinstein as chief executive officer amid a strategic restructuring and leadership transition of the board as the company turns its focus on the RenovaroCube AI platform.

The company said it will realign its resources to focus on optimizing and commercializing RenovaroCube, which is a platform for multi-cancer early detection and patient monitoring.

Weinstein succeeds Mark Dybul, who resigned from the company on Oct. 12, according to a Securities and Exchange Commission filing.

As part of the leadership transition, the biotechnology company's entire board is being replaced with a five-member slate that includes Weinstein. Maurice van Tilburg succeeds Rene Sindlev as board chair while Douglas W. Calder, James A. McNulty and Mark A. Collins have been named as new board members, the company said.

The company's shares were up nearly 22% in recent trading.

Price: 0.86, Change: +0.15, Percent Change: +21.89